Funding Innovative Medicines Whitepaper

HomeResourcesFunding Innovative Medicines Whitepaper

Australia has a unique opportunity to reform the way it evaluates and funds medicines and vaccines, to
ensure that Australians are among the first in the world to access new technologies. This is a policy
objective of the Australian Government that is shared by the medicines industry. Reforms to Australia’s
Pharmaceutical Benefits Scheme (PBS) and National Immunisation Program (NIP) are needed so that
Australian patients can access medicines and vaccines like other similar countries.

Related Resources

Want To Find Out More?

Are you interested in learning more about Biointelect, including our current white paper submissions and health policy related work?

Get in touch with our team to discover how we’re advancing healthcare for all and how you can harness our intellect and proven expertise in bringing innovative life science to market.

Download Your PDF

To access the PDF, please fill out the form below. Once completed, you’ll be redirected to our folder where you can download all available resources.

Please enable JavaScript in your browser to complete this form.